Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salmonella enterica serovar Typhi flagellar H-antigen, primarily encoded by the fliC gene (which expresses the H:d antigen), is the major structural protein of the bacterial flagellum. It plays a critical role in bacterial motility, chemotaxis, and initial adhesion to host epithelial cells during the pathogenesis of typhoid fever. As a highly exposed surface protein, the H-antigen is a major target of the host immune system, recognized by Toll-like receptor 5 (TLR5) to trigger innate immune signaling. In clinical medicine, the H-antigen is widely utilized as a diagnostic marker in the Widal agglutination test to detect active or past typhoid infections. Furthermore, it serves as a key target and adjuvant in vaccine development, including live attenuated typhoid vaccines (such as Ty21a) and novel conjugate vaccines, where it stimulates protective humoral and cellular immune responses.
Stimulates the production of protective anti-flagellar antibodies and activates Toll-like receptor 5 (TLR5) to induce innate and adaptive immune responses, preventing Salmonella Typhi infection and colonization.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella enterica serovar Typhi flagellar H-antigen (FliC).